| scholarly article | Q13442814 |
| P2093 | author name string | Aditi Sood | |
| Rajat Sandhir | |||
| Arpit Mehrotra | |||
| Sukhdev S Kamboj | |||
| P2860 | cites work | Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity | Q24317318 |
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction | Q29616762 | ||
| Mitochondrial control of cell death | Q29617739 | ||
| N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking | Q30486372 | ||
| Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease | Q31002507 | ||
| FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures | Q33209462 | ||
| Neuroprotective effect of N-acetylcysteine on neuronal apoptosis induced by a synthetic gingerdione compound: involvement of ERK and p38 phosphorylation | Q33258000 | ||
| Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease | Q33292417 | ||
| N-acetyl cysteine supplementation prevents impairment of spatial working memory functions in rats following exposure to hypobaric hypoxia | Q33437587 | ||
| Mitochondrial glutathione, a key survival antioxidant | Q33649876 | ||
| Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease | Q45301207 | ||
| Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat | Q45302144 | ||
| Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study | Q45306906 | ||
| Role of HSP27 and reduced glutathione in modulating malathion-induced apoptosis of human peripheral blood mononuclear cells: ameliorating effect of N-acetylcysteine and curcumin. | Q45927775 | ||
| N-acetylcysteine prevents mitochondria from oxidative injury induced by conventional peritoneal dialysate in human peritoneal mesothelial cells | Q46047939 | ||
| N-acetylcysteine suppresses oxidative stress in experimental rats with subarachnoid hemorrhage | Q46098947 | ||
| Astrocytic proliferation and mitochondrial dysfunction induced by accumulated glutaric acidemia I (GAI) metabolites: possible implications for GAI pathogenesis | Q46310683 | ||
| Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes | Q46358585 | ||
| Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism | Q46560087 | ||
| Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy | Q46966545 | ||
| Lipid peroxidation associated cardiolipin loss and membrane depolarization in rat brain mitochondria | Q46970524 | ||
| Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats | Q48250255 | ||
| Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia | Q48307610 | ||
| Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? | Q48317832 | ||
| Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport | Q48435478 | ||
| Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats | Q48627086 | ||
| Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury | Q49090197 | ||
| Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. | Q52540884 | ||
| Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. | Q52547831 | ||
| Studies on energy-linked reactions: modified mitochondrial ATPase of oligomycin-resistant mutants of Saccharomyces cerevisiae. | Q54636781 | ||
| Recent advances in understanding the pathogenesis of Huntington's disease | Q33650539 | ||
| Mitochondria, oxygen free radicals, disease and ageing | Q33922972 | ||
| Invited review: manganese superoxide dismutase in disease | Q33944740 | ||
| Energetics in the pathogenesis of neurodegenerative diseases | Q33944937 | ||
| Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin | Q35013054 | ||
| Preservation of cellular glutathione status and mitochondrial membrane potential by N-acetylcysteine and insulin sensitizers prevent carbonyl stress-induced human brain endothelial cell apoptosis | Q35205624 | ||
| Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? | Q35254212 | ||
| Reactive oxygen species and the central nervous system | Q35389986 | ||
| The effects of stress and aging on glutathione metabolism | Q36151893 | ||
| 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. | Q36318579 | ||
| Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review | Q36386914 | ||
| Selective neuronal degeneration in Huntington's disease | Q36597920 | ||
| Mechanisms of neurodegeneration in Huntington's disease. | Q37202865 | ||
| Watching the watcher: regulation of p53 by mitochondria | Q37401359 | ||
| 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. | Q37718532 | ||
| Neural mechanisms of ageing and cognitive decline | Q37718609 | ||
| Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? | Q37767300 | ||
| Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase | Q39184357 | ||
| 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. | Q39449440 | ||
| Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. | Q40459745 | ||
| Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release | Q40551652 | ||
| An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study | Q41093578 | ||
| Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid | Q41711372 | ||
| p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. | Q42125448 | ||
| Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. | Q42438521 | ||
| Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats | Q42460820 | ||
| Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid | Q42464071 | ||
| Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid. | Q42512046 | ||
| Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system | Q42965732 | ||
| Inhibition of mitochondrial respiratory chain in the brain of rats after renal ischemia is prevented by N-acetylcysteine and deferoxamine | Q43083214 | ||
| N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats exposed to cadmium | Q43095424 | ||
| N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms | Q43478194 | ||
| Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases | Q43599271 | ||
| Behavioral and biochemical effects of glutathione depletion in the rat brain | Q43698402 | ||
| Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach | Q43893354 | ||
| Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid. | Q44079753 | ||
| Proteomic and oxidative stress analysis in human brain samples of Huntington disease. | Q44737699 | ||
| Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid | Q44792354 | ||
| Increased formation of reactive oxygen species, but no changes in glutathione peroxidase activity, in striata of mice transgenic for the Huntington's disease mutation | Q44852260 | ||
| Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice | Q45252402 | ||
| Mitochondrial defect in Huntington's disease caudate nucleus | Q45291734 | ||
| p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease | Q45297400 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| acetylcysteine | Q375613 | ||
| P304 | page(s) | 145-157 | |
| P577 | publication date | 2012-02-09 | |
| P1433 | published in | Neurodegenerative Diseases | Q15764918 |
| P1476 | title | N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease | |
| P478 | volume | 9 |
| Q45303159 | 4-hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington's disease. |
| Q38174451 | A mitochondrial basis for Huntington's disease: therapeutic prospects |
| Q38742940 | Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor. |
| Q33854662 | Antioxidant supplement inhibits skeletal muscle constitutive autophagy rather than fasting-induced autophagy in mice |
| Q37641278 | Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats |
| Q39203995 | Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy |
| Q43687507 | Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease |
| Q48301047 | Cytoskeleton of cortical astrocytes as a target to proline through oxidative stress mechanisms |
| Q26822726 | Dysregulation of glutathione homeostasis in neurodegenerative diseases |
| Q90029591 | Exaggerated mitophagy: a weapon of striatal destruction in the brain? |
| Q64075331 | Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications |
| Q52621890 | Mitochondrial Agents for Bipolar Disorder. |
| Q38086474 | Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy |
| Q46261230 | Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy |
| Q39014966 | Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime |
| Q37603362 | N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases. |
| Q45290091 | N-Acetylcysteine for Huntington's? |
| Q90394758 | N-Acetylcysteine protects against intrauterine growth retardation-induced intestinal injury via restoring redox status and mitochondrial function in neonatal piglets |
| Q50073097 | N-acetyl-l-cysteine Prevents Bile Duct Ligation Induced Renal Injury by Modulating Oxidative Stress |
| Q24568289 | N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities |
| Q38209914 | Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries |
| Q28533959 | Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats |
| Q35148188 | Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease |
| Q46360388 | Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II. |
| Q87241483 | [Huntington's disease] |
Search more.